QinetiQ Group PLC Logo

QinetiQ Group PLC

A science and engineering company providing technology for defence and security sectors.

QQ | IL

Overview

Corporate Details

ISIN(s):
GB00B0WMWD03 (+1 more)
LEI:
213800S8OBDOZMCMUW34
Country:
United Kingdom
Address:
CODY TECHNOLOGY PARK, GU14 0LX FARNBOROUGH

Description

QinetiQ Group PLC is a science and engineering company that provides technology-based products and services primarily to the global defence and security sectors. The company's core activities include research and development, advisory services, and comprehensive test and evaluation (T&E) for air, land, and maritime systems. Key offerings encompass uncrewed air, land, and surface target systems for live-fire training and weapons system assessment; cybersecurity services and training; and advanced training and mission rehearsal solutions. QinetiQ focuses on mission-led innovation, applying its expertise to modernize military platforms and enhance critical technologies to address complex operational challenges for its customers.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2014-11-19 18:33
Transaction in Own Shares
English 12.4 KB
2014-11-18 19:24
Transaction in Own Shares
English 12.4 KB
2014-11-18 10:27
Holding(s) in Company
English 52.1 KB
2014-11-17 18:59
Transaction in Own Shares
English 14.3 KB
2014-11-14 18:42
Transaction in Own Shares
English 12.4 KB
2014-11-14 12:33
Director/PDMR Shareholding
English 11.9 KB
2014-11-14 12:33
Director/PDMR Shareholding
English 11.9 KB
2014-11-13 18:28
Transaction in Own Shares
English 12.4 KB
2014-11-12 18:12
Transaction in Own Shares
English 12.4 KB
2014-11-12 17:11
Holding(s) in Company
English 48.2 KB
2014-11-11 18:23
Transaction in Own Shares
English 13.4 KB
2014-11-11 10:29
Holding(s) in Company
English 52.7 KB
2014-11-10 18:05
Transaction in Own Shares
English 12.4 KB
2014-11-07 18:23
Transaction in Own Shares
English 12.4 KB
2014-11-06 18:15
Transaction in Own Shares
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all QinetiQ Group PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for QinetiQ Group PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for QinetiQ Group PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.